Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Vinci Concessions SAS and its subsidiary SunMind SAS in connection with its acquisition of Helios Nordic Energy AB from Magnora ASA, management and early investors
Mandate

Vinge advises Vinci Concessions SAS and its subsidiary SunMind SAS in connection with its acquisition of Helios Nordic Energy AB from Magnora ASA, management and early investors

May 30, 2024 M&A Employment and Benefits Environmental Law Real Estate and Construction Commercial Agreements Corporate Crime & Compliance EU, Competition and Regulatory Energy

Helios Nordic Energy specialises in developing solar farms and batteries to store energy until they become Ready to Build in the Nordics and Baltics.

The acquisition will enable SunMind to further enrich its expertise in renewable solar energy and other sources of renewable energy.

The current owners of Helios will receive an upfront payment of approximately EUR 73 million as well as a substantial earnout component tied to Helios's portfolio of unsold projects stretching over five years from closing.

The acquisition is subject to customary regulatory approvals.

Vinge's team primarily consisted of Peter Sundgren, Martin E Svanberg, Hanna Jansson and Fredrik Löwenclou (M&A), Amelia Rihs (Employment), Johan Cederblad and Lina Österberg (Environmental law), Kristoffer Larsson and Jasdeep Singh (Real Estate), Jolene Reimersson och Mario Saad (Commercial Agreements), Mia Falk (Compliance), David Olander and Lovisa Lewin (Regulatory),  Cecilia Loctander and  Caroline Löv (Transaction Support Coordinators).

Related

Vinge has advised Egetis Therapeutics in connection with a directed share issue

 Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025

Vinge worked with funds advised by Agilitas on the buy-out of Vivicta (previously Tietoevry Tech Services), including on the issuance of senior secured bonds and on entering into a super senior RCF

 Vinge, together with O’Melveny as lead counsel and Avance, worked with funds advised by Agilitas Private Equity LLP (“Agilitas”), the pan-European mid-market private equity firm, in their backing of Vivicta. The buy-out was previously announced on 24 March 2025 and closed on 2 September 2025.
October 03, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 671.5 million

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of approx. SEK 671.5 million before transaction costs.
October 03, 2025